Yuyu Pharma (000220) - Total Liabilities

Latest as of September 2025: ₩63.32 Billion KRW ≈ $42.91 Million USD

Based on the latest financial reports, Yuyu Pharma (000220) has total liabilities worth ₩63.32 Billion KRW (≈ $42.91 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Yuyu Pharma annual equity growth to track the company's year-over-year net asset growth rate.

Yuyu Pharma - Total Liabilities Trend (2011–2024)

This chart illustrates how Yuyu Pharma's total liabilities have evolved over time, based on quarterly financial data. See cash generation quality of Yuyu Pharma to measure how efficiently the company converts operating cash flow to free cash.

Yuyu Pharma Competitors by Total Liabilities

The table below lists competitors of Yuyu Pharma ranked by their total liabilities.

Company	Country	Total Liabilities
Alchera Inc. KQ:347860	Korea	₩15.26 Billion
Acanthe Développement PA:ACAN	France	€21.07 Million
KCP Sugar and Industries Corporation Limited NSE:KCPSUGIND	India	Rs1.18 Billion
Suparma Tbk JK:SPMA	Indonesia	Rp1.07 Trillion
Eastern Star Real Estate Public Company Limited BK:ESTAR	Thailand	฿2.20 Billion
Yotta Acquisition Corporation Common Stock NASDAQ:YOTA	USA	$8.47 Million
Wooshin System KO:017370	Korea	₩240.80 Billion
KLX Energy Services Holdings Inc NASDAQ:KLXE	USA	$418.60 Million

Liability Composition Analysis (2011–2024)

This chart breaks down Yuyu Pharma's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Yuyu Pharma worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.77	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.49	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.31	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Yuyu Pharma's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Yuyu Pharma (2011–2024)

The table below shows the annual total liabilities of Yuyu Pharma from 2011 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩72.62 Billion ≈ $49.22 Million	-6.72%
2023-12-31	₩77.86 Billion ≈ $52.76 Million	+8.39%
2022-12-31	₩71.83 Billion ≈ $48.68 Million	+11.71%
2021-12-31	₩64.30 Billion ≈ $43.58 Million	+69.82%
2020-12-31	₩37.86 Billion ≈ $25.66 Million	-19.73%
2019-12-31	₩47.17 Billion ≈ $31.97 Million	-2.44%
2018-12-31	₩48.35 Billion ≈ $32.77 Million	+25.08%
2017-12-31	₩38.66 Billion ≈ $26.20 Million	+17.11%
2016-12-31	₩33.01 Billion ≈ $22.37 Million	+7.88%
2015-12-31	₩30.60 Billion ≈ $20.73 Million	+2.29%
2014-12-31	₩29.91 Billion ≈ $20.27 Million	+24.69%
2013-12-31	₩23.99 Billion ≈ $16.26 Million	+25.08%
2012-12-31	₩19.18 Billion ≈ $13.00 Million	-9.87%
2011-12-31	₩21.28 Billion ≈ $14.42 Million	--

About Yuyu Pharma

KO:000220 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$39.15 Million

₩57.77 Billion KRW

Market Cap Rank

#22765 Global

#1451 in Korea

Share Price

₩3570.00

Change (1 day)

+1.71%

52-Week Range

₩3435.00 - ₩4740.00

All Time High

₩16106.03